PH22753A - Diazine-ethenylohenyl oxamic acids and esters and salts thereof - Google Patents
Diazine-ethenylohenyl oxamic acids and esters and salts thereofInfo
- Publication number
- PH22753A PH22753A PH31168A PH31168A PH22753A PH 22753 A PH22753 A PH 22753A PH 31168 A PH31168 A PH 31168A PH 31168 A PH31168 A PH 31168A PH 22753 A PH22753 A PH 22753A
- Authority
- PH
- Philippines
- Prior art keywords
- carbon atoms
- alkoxy
- hydrogen
- salts
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/12—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/16—Halogen atoms; Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Materials For Medical Uses (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52852283A | 1983-09-01 | 1983-09-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH22753A true PH22753A (en) | 1988-11-28 |
Family
ID=24106021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH31168A PH22753A (en) | 1983-09-01 | 1984-08-30 | Diazine-ethenylohenyl oxamic acids and esters and salts thereof |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0137979B1 (xx) |
JP (1) | JPS60142968A (xx) |
KR (1) | KR900001217B1 (xx) |
AT (1) | ATE38224T1 (xx) |
AU (1) | AU569541B2 (xx) |
CA (1) | CA1219873A (xx) |
CS (1) | CS241100B2 (xx) |
DD (1) | DD227964A5 (xx) |
DE (1) | DE3474817D1 (xx) |
DK (1) | DK158725C (xx) |
ES (1) | ES535572A0 (xx) |
FI (1) | FI84477C (xx) |
GR (1) | GR80245B (xx) |
HU (1) | HU192576B (xx) |
IE (1) | IE59035B1 (xx) |
IL (1) | IL72833A (xx) |
NO (1) | NO843477L (xx) |
NZ (1) | NZ209405A (xx) |
PH (1) | PH22753A (xx) |
PT (1) | PT79163B (xx) |
SU (1) | SU1342410A3 (xx) |
ZA (1) | ZA846826B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62145049A (ja) * | 1985-12-18 | 1987-06-29 | Mitsubishi Chem Ind Ltd | アミノスチリル化合物及びそれを有効成分とするロイコトリエンきつ抗剤 |
WO1992000963A1 (en) * | 1990-07-12 | 1992-01-23 | Yoshitomi Pharmaceutical Industries, Ltd. | Styryl compounds and use thereof as medicine |
JP2832923B2 (ja) * | 1990-07-13 | 1998-12-09 | 吉富製薬株式会社 | スチリル化合物およびその医薬用途 |
WO1999035140A1 (en) * | 1998-01-12 | 1999-07-15 | Novartis Ag | PYRIDINYLPYRIMIDINE AMINES AS IMMUNOGLOBULINE E (IgE) SYNTHESIS INHIBITORS |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1259685A (en) * | 1969-04-03 | 1972-01-12 | Soc D Etudes Prod Chimique | Amino-pyrimidine derivatives |
US3993679A (en) * | 1972-12-20 | 1976-11-23 | The Upjohn Company | Cyano phenylene dioxamic molecules |
US4054666A (en) * | 1973-03-23 | 1977-10-18 | American Home Products Corporation | Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives |
US3953468A (en) * | 1974-03-15 | 1976-04-27 | The Upjohn Company | 3-Cyano thiophen-2-yl oxamic acid and derivatives |
CA1066714A (en) * | 1974-06-10 | 1979-11-20 | John B. Wright | Pharmaceutical n-phenyloxamic acid derivatives |
DE2828091A1 (de) * | 1978-06-27 | 1980-01-10 | Boehringer Sohn Ingelheim | 4-substituierte thiazoloxamsaeuren sowie ihre salze und ester |
JPS5761028A (en) * | 1980-09-30 | 1982-04-13 | Sanyo Chem Ind Ltd | Formation of heat-insulating primer layer and heat-insulating structure |
-
1984
- 1984-08-23 DE DE8484110036T patent/DE3474817D1/de not_active Expired
- 1984-08-23 AT AT84110036T patent/ATE38224T1/de not_active IP Right Cessation
- 1984-08-23 EP EP84110036A patent/EP0137979B1/en not_active Expired
- 1984-08-29 SU SU843784980A patent/SU1342410A3/ru active
- 1984-08-29 GR GR80245A patent/GR80245B/el unknown
- 1984-08-30 FI FI843417A patent/FI84477C/fi not_active IP Right Cessation
- 1984-08-30 CS CS846545A patent/CS241100B2/cs unknown
- 1984-08-30 PH PH31168A patent/PH22753A/en unknown
- 1984-08-31 HU HU843293A patent/HU192576B/hu not_active IP Right Cessation
- 1984-08-31 CA CA000462219A patent/CA1219873A/en not_active Expired
- 1984-08-31 PT PT79163A patent/PT79163B/pt not_active IP Right Cessation
- 1984-08-31 DK DK418484A patent/DK158725C/da not_active IP Right Cessation
- 1984-08-31 NZ NZ209405A patent/NZ209405A/en unknown
- 1984-08-31 KR KR1019840005354A patent/KR900001217B1/ko not_active IP Right Cessation
- 1984-08-31 JP JP59182553A patent/JPS60142968A/ja active Pending
- 1984-08-31 NO NO843477A patent/NO843477L/no unknown
- 1984-08-31 AU AU32600/84A patent/AU569541B2/en not_active Ceased
- 1984-08-31 IL IL72833A patent/IL72833A/xx not_active IP Right Cessation
- 1984-08-31 IE IE223784A patent/IE59035B1/en not_active IP Right Cessation
- 1984-08-31 ZA ZA846826A patent/ZA846826B/xx unknown
- 1984-08-31 DD DD84266851A patent/DD227964A5/de not_active IP Right Cessation
- 1984-08-31 ES ES535572A patent/ES535572A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
FI84477C (fi) | 1991-12-10 |
ZA846826B (en) | 1986-04-30 |
PT79163B (en) | 1986-11-18 |
DK158725B (da) | 1990-07-09 |
CS654584A2 (en) | 1985-07-16 |
ES8505934A1 (es) | 1985-06-16 |
CA1219873A (en) | 1987-03-31 |
ATE38224T1 (de) | 1988-11-15 |
DE3474817D1 (en) | 1988-12-01 |
KR900001217B1 (ko) | 1990-02-28 |
DK158725C (da) | 1990-12-10 |
SU1342410A3 (ru) | 1987-09-30 |
CS241100B2 (en) | 1986-03-13 |
ES535572A0 (es) | 1985-06-16 |
FI84477B (fi) | 1991-08-30 |
EP0137979B1 (en) | 1988-10-26 |
IE842237L (en) | 1985-03-01 |
IL72833A0 (en) | 1984-11-30 |
HU192576B (en) | 1987-06-29 |
HUT37129A (en) | 1985-11-28 |
IL72833A (en) | 1987-09-16 |
GR80245B (en) | 1985-01-03 |
NZ209405A (en) | 1987-05-29 |
DK418484D0 (da) | 1984-08-31 |
EP0137979A1 (en) | 1985-04-24 |
NO843477L (no) | 1985-03-04 |
KR850002258A (ko) | 1985-05-10 |
FI843417A0 (fi) | 1984-08-30 |
FI843417A (fi) | 1985-03-02 |
DK418484A (da) | 1985-03-02 |
JPS60142968A (ja) | 1985-07-29 |
PT79163A (en) | 1984-09-01 |
AU3260084A (en) | 1985-03-07 |
AU569541B2 (en) | 1988-02-04 |
IE59035B1 (en) | 1993-12-15 |
DD227964A5 (de) | 1985-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU565490B2 (en) | Dihydrobenzopyran derivatives | |
DE69120500D1 (de) | Azasteroide zur Behandlung prostatischer Hypertrophie, ihre Herstellung und Verwendung | |
FI820998L (fi) | 9-/2-(3-indolyl)etyl/-1-oxa-4,9-diazaspiro/5,5/undekan-3-oner | |
IE820401L (en) | N-£4-(indolyl)-piperidino-alkyl|-benzimidazolines | |
DE3474817D1 (en) | Diazine-ethenylphenyl oxamic acids and esters and salts thereof | |
AU605493B2 (en) | Novel 8-(lower alkyl) bicyclo{4.2.0}-octane derivatives with valuable therapeutic properties | |
EP0396839A3 (en) | Naphthalenepropionic acid salts | |
SE8703494D0 (sv) | Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat | |
IL72681A (en) | 4-alkyl-5-haloimidazole-1-carboxylic acid esters and amides,their preparation and their use as nitrification inhibitors | |
HUT34740A (en) | Process for preparing piperazine and homopiperazine derivatives | |
AU2742288A (en) | Novel compound effective as cerebral insufficiency improver | |
JPS6479178A (en) | Thiazole derivative |